Pharmacy - Antimicrobials News & Articles

461 Contemporary tetracycline susceptibility testing: doxycycline MIC methods and interpretive criteria (CLSI and EUCAST) performance when testing Gram-positive pathogens Diagnostic Microbiology and Infectious Disease, March 25, 2013

462 Antimicrobial prescribing in nursing homes in Finland: results of three point prevalence surveys Infection, March 25, 2013    Clinical Article

463 Candida albicans Flu1-Mediated Efflux of Salivary Histatin 5 Reduces Its Cytosolic Concentration and Fungicidal Activity Antimicrobial Agents and Chemotherapy, March 25, 2013    Clinical Article

464 Contribution of Topoisomerase IV Mutation to Quinolone Resistance in Mycoplasma genitalium Antimicrobial Agents and Chemotherapy, March 25, 2013    Review Article

465 Risk factors and outcomes in patients with carbapenem-resistant Acinetobacter infection Scandinavian Journal of Infectious Diseases, March 25, 2013    Clinical Article

466 Spectrum and potency of ceftaroline tested against leading pathogens causing skin and soft-tissue infections in Europe (2010) International Journal of Antimicrobial Agents, March 25, 2013    Clinical Article

467 Use of rifabutin for the treatment of a latent tuberculosis infection in a patient after solid organ transplantation Liver Transplantation, March 25, 2013

468 The NAT2 tag SNP rs1495741 correlates with the susceptibility of antituberculosis drug-induced hepatotoxicity Pharmacogenetics and genomics, March 25, 2013    Review Article

469 Intraoperative Vancomycin Pharmacokinetics in Cardiac Surgery With or Without Cardiopulmonary Bypass Annals of Pharmacotherapy, March 22, 2013    Clinical Article

470 Risks and Benefits Associated With Antibiotic Use for Acute Respiratory Infections: A Cohort Study Full Text Annals of Family Medicine, March 22, 2013    Clinical Article

471 Pharmacokinetics, Metabolism, and Excretion of the Antiviral Drug Arbidol in Humans Antimicrobial Agents and Chemotherapy, March 22, 2013    Clinical Article

472 Benefits From Sustained Virologic Response to Pegylated Interferon Plus Ribavirin in HIV/Hepatitis C Virus-Coinfected Patients With Compensated Cirrhosis Clinical Infectious Diseases, March 22, 2013    Clinical Article

473 Combined Intravenous and Intraventricular Administration of Colistin Methanesulfonate in Critically Ill Patients with Central Nervous System Infection Antimicrobial Agents and Chemotherapy, March 22, 2013    Clinical Article

474 Population Pharmacokinetics of Intramuscular Artesunate in African Children With Severe Malaria: Implications for a Practical Dosing Regimen Clinical Pharmacology & Therapeutics, March 22, 2013    Clinical Article

475 Increasing Failure of Miltefosine in the Treatment of Kala-azar in Nepal and the Potential Role of Parasite Drug Resistance, Reinfection, or Noncompliance Clinical Infectious Diseases, March 22, 2013    Clinical Article

476 Target Gene Sequencing To Define the Susceptibility of Neisseria meningitidis to Ciprofloxacin Antimicrobial Agents and Chemotherapy, March 22, 2013    Clinical Article

477 Time Series Analysis as a Tool To Predict the Impact of Antimicrobial Restriction in Antibiotic Stewardship Programs Using the Example of Multidrug-Resistant Pseudomonas aeruginosa Antimicrobial Agents and Chemotherapy, March 22, 2013    Review Article

478 Anti-malarial IgG subclasses pattern and FcgammaRIIa (CD32) polymorphism among pregnancy-associated malaria in semi-immune Saudi women Full Text Malaria Journal, March 22, 2013    Clinical Article

479 Trypanocidal activity of salinomycin is due to sodium influx followed by cell swelling Full Text Parasites & Vectors, March 22, 2013    Clinical Article

480 Acquired Bartter-Like Syndrome Associated with Colistin Use in a Preterm Infant Renal Failure, March 22, 2013    Clinical Article

1 Continuous versus intermittent infusions of antibiotics for the treatment of severe acute infections Cochrane Reviews, March 29, 2013    Review Article

2 Telavancin and Daptomycin activity against methicillin-resistant Staphylococcus aureus strains after vancomycin resistance selection in vitro Journal of Medical Microbiology, April 22, 2013

3 Early Use of Daptomycin Versus Vancomycin for Methicillin-Resistant Staphylococcus aureus Bacteremia With Vancomycin Minimum Inhibitory Concentration >1 mg/L: A Matched Cohort Study Clinical Infectious Diseases, April 1, 2013

4 Infective Endocarditis New England Journal of Medicine, April 12, 2013

5 Clostridium Difficile Colitis: Review of the Therapeutic Approach American Journal of Therapeutics, April 8, 2013

6 Pharmacokinetics of colistin in critically ill patients with multidrug-resistant Gram-negative bacilli infection European Journal of Clinical Pharmacology, April 3, 2013

7 Effect of Azithromycin on Anticoagulation-Related Outcomes in Geriatric Patients Receiving Warfarin Clinical Therapeutics, April 22, 2013

8 Antifungal Therapy for Invasive Aspergillosis U.S. Pharmacist, April 26, 2013    Free full text

9 Infective Endocarditis New England Journal of Medicine, April 24, 2013    Review Article

10 Effectiveness of a Double-Carbapenem Regimen for Infections in Humans Due to Carbapenemase-Producing Pandrug-Resistant Klebsiella pneumoniae Antimicrobial Agents and Chemotherapy, April 23, 2013

11 Update on the Antimicrobial Management of Foot Infections in Patients With Diabetes Clinical Diabetes, April 18, 2013    Free full text    Review Article

12 Importance of Relating Efficacy Measures to Unbound Drug Concentrations for Anti-Infective Agents Clinical Microbiology Reviews, April 4, 2013

13 Is It Time To Replace Vancomycin In The Treatment Of MRSA Infections Clinical Infectious Diseases, April 4, 2013

14 Clinical Trial: Comparative effectiveness of cephalexin plus trimethoprim-sulfamethoxazole vs. cephalexin alone for treatment of uncomplicated cellulitis: A randomized controlled trial Clinical Infectious Diseases, March 21, 2013

15 Linezolid versus vancomycin for meticillin-resistant Staphylococcus aureus infection: a meta-analysis of randomised controlled trials International Journal of Antimicrobial Agents, April 23, 2013    Evidence Based Medicine

16 Clinical outcomes of tigecycline alone or in combination with other antimicrobial agents for the treatment of patients with healthcare-associated multidrug-resistant Acinetobacter baumannii infections European Journal of Clinical Microbiology & Infectious Diseases, April 5, 2013

17 Tigecycline: an update Diagnostic Microbiology and Infectious Disease, February 5, 2013

18 Effect of adequate single-drug versus combination antimicrobial therapy on mortality in Pseudomonas aeruginosa bloodstream infections. A post hoc analysis of a prospective cohort Clinical Infectious Diseases, April 17, 2013

19 Carbapenem resistance in Acinetobacter baumannii: laboratory challenges, mechanistic insights and therapeutic strategies Expert Review of Anti-infective Therapy, April 19, 2013

20 Time to first antibiotic dose for patients hospitalised with community-acquired pneumonia International Journal of Antimicrobial Agents, April 19, 2013